We are live on ! Find out more
SIAU

SB Investment Advisers (UK) Portfolio holdings

AUM $7.73B
1-Year Est. Return 2.35%
This Fund
S&P 500
This Quarter Est. Return
-18.58%
1 Year Est. Return
-2.35%
3 Year Est. Return
+51.59%
5 Year Est. Return
-28.22%
10 Year Est. Return
–
AUM
$7.73B
AUM Growth
-$2.27B
Cap. Flow
-$415M
Cap. Flow %
-5.37%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
4
Closed
–

Top Buys

No buys this quarter

Top Sells

1
ROIV icon
Roivant Sciences
ROIV
+$353M
2
COMP icon
Compass
COMP
+$32.1M
3
VIR icon
Vir Biotechnology
VIR
+$17.3M
4
NRGV icon
Energy Vault
NRGV
+$12.4M

Sector Composition

1 Consumer Discretionary 71.79%
2 Technology 19.6%
3 Healthcare 5.87%
4 Real Estate 2.08%
5 Utilities 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPNG icon
1
Coupang
CPNG
$30.3B
$5.47B 70.74%
289,542,259
– –
GRAB icon
2
Grab
GRAB
$15.3B
$1.47B 19.03%
401,796,672
– –
RLAY icon
3
Relay Therapeutics
RLAY
$4.22B
$278M 3.59%
27,904,963
– –
COMP icon
4
Compass
COMP
$9.1B
$161M 2.08%
22,004,702
-3,058,271
-12% -$32.1M
VIR icon
5
Vir Biotechnology
VIR
$1.59B
$98.1M 1.27%
10,948,093
-2,168,884
-17% -$17.3M
AUR icon
6
Aurora
AUR
$11.7B
$81.6M 1.06%
19,811,760
– –
ROIV icon
7
Roivant Sciences
ROIV
$24.4B
$74M 0.96%
2,671,732
-13,741,871
-84% -$353M
NRGV icon
8
Energy Vault
NRGV
$547M
$51.3M 0.66%
15,535,631
-3,000,000
-16% -$12.4M
YMM icon
9
Full Truck Alliance
YMM
$9.69B
$43.8M 0.57%
5,272,390
– –
DNA icon
10
Ginkgo Bioworks
DNA
$542M
$3.74M 0.05%
610,729
– –

Similar funds

WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $7.67B AUM 21.09% 1-Year Est. Return

SB Investment Advisers (UK)'s Q1 2026 Portfolio in Review

As of Q1 2026, SB Investment Advisers (UK) held 10 positions worth $7.73B, down 23% from $9.99B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SB Investment Advisers (UK) withdrew a net $415M in Q1 2026, reducing 4 holdings. Its largest reduction was Roivant Sciences, cutting an estimated $353M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 72% of assets, up from 69% a quarter earlier, followed by Technology and Healthcare.

  • SB Investment Advisers (UK)'s biggest Q1 2026 reduction was Roivant Sciences, cutting an estimated $353M.
  • SB Investment Advisers (UK)'s ten largest holdings make up 100% of its $7.73B portfolio in Q1 2026.
  • SB Investment Advisers (UK) opened 0 new positions and closed 0 in Q1 2026.
  • SB Investment Advisers (UK)'s portfolio value fell 23% quarter-over-quarter to $7.73B.

Based on SB Investment Advisers (UK)'s 13F filing for Q1 2026, filed 18 May 2026.